MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

The in vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.

Goldstein EJ, Citron DM, Merriam VC, Warren YA, Tyrrell KL, Fernandez HT

From The R M Alden Research Laboratory, Santa Monica, CA 90404 and the UCLA School of Medicine, Los Angeles, CA 90073.

Against 443 aerobic and anaerobic bacteria isolated from diabetic foot infections, ceftobiprole MIC 90s [microg/ml] were: MRSA, 1; MSSA and S. lugdunensis, 0.5; Anaerococcus prevotii, 0.125; Finegoldia magna, 0.5; Peptoniphilus asaccharolyticus, 1, and Peptostreptococcus anaerobius, 4; Escherichia coli and Enterobacter species, 0.125; Klebsiella species, 2, and Pseudomonas aeruginosa, 8.

Published 19 September 2006 in Antimicrob Agents Chemother.
Full-text of this article is available online (may require subscription).

© 2004-2008 MRSA Research Today. All Rights Reserved.